Home › Funds › Opaleye Management Inc. › ETON

Opaleye Management Inc. position in ETON

ETON PHARMACEUTICALS INC COM · Health Care

Opaleye Management Inc. reported holding 2,860,000 shares of ETON (ETON PHARMACEUTICALS INC COM) in its Q2 2026 13F filing — a position valued at US$103.5M, representing 9.38% of its reported portfolio and ranking #2 among its reported holdings. Opaleye Management Inc. has disclosed ETON holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)2.86M sh
Reported value held$103.53M
Portfolio Weight9.38%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Opaleye Management Inc.'s ETON position evolved

Opaleye Management Inc. first disclosed a stake in ETON in Q3 2023 at 2,430,270 shares (US$10.1M). The position peaked in Q2 2026 at 2,860,000 shares, worth US$103.5M. Across 12 filings, Opaleye Management Inc. increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 2,860,000 shares valued at US$103.5M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.43M $10.13M New
Q4 2023 2.53M $11.08M Add
Q1 2024 2.45M $9.17M Reduce
Q2 2024 2.40M $7.88M Reduce
Q3 2024 2.78M $16.68M Add
Q4 2024 2.85M $37.99M Add
Q1 2025 2.85M $37.02M Hold
Q2 2025 2.86M $40.76M Hold
Q3 2025 2.86M $62.15M Hold
Q4 2025 2.86M $48.36M Hold
Q1 2026 2.86M $70.58M Hold
Q2 2026 2.86M $103.53M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ETON and 13F data

ETON (ETON PHARMACEUTICALS INC COM) is a Health Care company. 64 other funds we track also report a position in ETON — the largest reported positions include EcoR1 Capital, LLC (US$78.6M), Nantahala Capital Management, LLC (US$42.6M), National Philanthropic Trust (US$17.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ETON

All ETON fund holders →

FAQ

How long has Opaleye Management Inc. held ETON?

Opaleye Management Inc. has disclosed ETON holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Opaleye Management Inc.'s current position in ETON?

As of Q2 2026, Opaleye Management Inc. holds 2.86M shares of ETON (ETON PHARMACEUTICALS INC COM), valued at $103.53M, representing 9.38% of its reported portfolio and ranking #2.

Has Opaleye Management Inc. been buying or selling ETON?

In the latest 13F filing (Q2 2026), Opaleye Management Inc. held unchanged its position in ETON. The position peaked in Q2 2026 at 2.86M shares.

Which other funds hold ETON?

Other major institutional holders of ETON include EcoR1 Capital, LLC, Nantahala Capital Management, LLC, National Philanthropic Trust, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.